← Back to screener

Forte Biosciences, Inc. FBRX

Rank #2344 · Nasdaq · $0.6B market cap
Audited by KPMG LLP, no going-concern flag in the latest filing.
Score
23.4
P/E
-17.2
P/B
17.27
ROE
-100.5%
Op. Margin
–%
Debt Ratio
26%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -17.2x, P/B 17.27x. Ranks in the top 84% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -100.5%. Ranks in the top 94% of the universe.

Safety ★★★★☆
Excellent

Debt ratio 26%. Ranks in the top 15% of the universe. Under 100% is generally considered a safe level.

Growth –
No data

Not enough historical filings to compute year-over-year growth yet.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2017–$-0.0B$-0.0B$-0.1B–-40
2018$0.0B$-0.0B$-0.0B$-0.1B-64673.5-23
2019$0.0B$-0.0B$-0.0B$-0.1B-91775.6-36
2020–$-0.0B$-0.0B$-0.0B–-1140
2021–$-0.0B$-0.0B$-0.0B–-1384
2022–$-0.0B$-0.0B$0.1B–-27
2023–$-0.0B$-0.0B$0.0B–1
2024–$-0.0B$-0.0B$0.0B–0
2025–$-0.0B$-0.0B$0.0B–26

← See the full screener